See what light can do.
Nano Detection Technology's universal detection system brings speed, accuracy, and scalability to infectious disease testing.
Utilizing a unique biosensor,
NDT has developed a novel diagnostic platform that can be applied to multiple markets.
Our current focus is on the human infectious disease detection market. This platform easily fits within the clinical lab or at near-patient testing locations.
NDT's exclusive Biochip IP
is the core of the system. 25 discrete light-sensing diodes enable multiplex capability and unparalleled sensitivity, enabling detection of light as low as 2.5E -15 the photons of a 100-watt light bulb.
An integrated system, featuring
a universal instrument platform, consumables, and software, all validated and produced under Good Manufacturing Practices.
BENEFITS OF THE NDT SYSTEM
With a single instrument, labs can detect multiple diseases using analyte-specific cassettes, making the NDT system a cost-effective and scalable solution for immediate deployment in fields as diverse as human diagnostics, veterinary medicine, and food safety.
MRSA/MSSA dual screening
Flu A & B
Sexually Transmitted Diseases
- More accurate, objective, and timely results compared to traditional methods.
- Easily scalable, accommodating both single specimen testing and batch screening processes.
- Improves labor utilization without loss of quality or increased turnaround time.
Through simplicity, accuracy, and timeliness, the NDT system is in position to provide tremendous positive impact in crucial areas of healthcare, including antibiotic stewardship, length of stay, and patient satisfaction.
NanoDetection Technology, Inc.
301 Industrial Drive
Franklin, Ohio 45005
Phone: (937) 790–1266
General inquires: email@example.com